Hopp Children`s Cancer Center NCT Heidelberg (KiTZ)
19th & 20th January 2017
Print Media Academy, Heidelberg
Preliminary Program available here.
“Deadly diseases are becoming curable”
Hundreds of children are diagnosed with cancer every year, and cancer remains the leading cause of disease-related death in children. The cause for many childhood cancers remains largely unknown.
Depending on the type of cancer diagnosed, children may receive different standard treatments, including combinations of radiation therapy, chemotherapy with or without stem cell transplant, or targeted therapy.
The innovative new Treatment and Research Center for Pediatric Oncology and Hematology will aim at fostering the translation of basic science discoveries into novel diagnostic approaches and therapies for children with cancer and serious non-malignant blood diseases. We aim to fully develop a synergistic interaction between the different basic, translational and clinical disciplines by uniting them under one roof. The ultimate goal is to turn more of the laboratory breakthroughs into lifesaving treatments for children.
This opening symposium is dedicated to the latest exciting topics in the field of pediatric cancer, and will be hosted by Stefan M. Pfister, Olaf Witt and Andreas Kulozik from January 19 – 20, 2017 in Heidelberg, Germany.
The meeting covers a broad repertoire of pediatric malignancies and hematological disorders represented by a panel of renowned national and international speakers as well as oral presentations from selected abstracts in each session.
The organizers are delighted to present an exciting and stimulating scientific program that covers a wide range of important aspects of cancer biology. Focus areas of this symposium include:
- Precision medicine & novel therapeutic concepts
- Heterogeneity, Clonal Evolution and Resistance
- Pre-clinical models
- Genomics and Molecular Classification
- Immunology & Immunotherapy
- Novel approaches in Radiotherapy
We are sincerely looking forward to hosting you in Heidelberg,
Stefan M. Pfister, Olaf Witt & Andreas Kulozik
Andreas Kulozik MD, PhD (University Hospital Heidelberg)
Professor of Pediatrics
Head of the Department of Pediatric Oncology, Hematology, Immunology and Pulmonology
Co-Director of the University of Heidelberg/EMBL Molecular Medicine Partnership Unit
Stefan Pfister, MD (DKFZ/University Hospital Heidelberg)
Professor of Pediatrics
Attending Physician for Pediatric Hematology and Oncology
Head of the Division of Pediatric Neurooncology, DKFZ
Olaf Witt, MD (DKFZ/University Hospital Heidelberg)
Professor of Pediatric Oncology
Deputy Chief of the Department for Pediatric Oncology, Hematology Immunology and Pulmonology
Division Head of the Clinical Cooperation Unit Pediatric Oncology, DKFZ
|Jean-Pierre Bourquin||University of Zurich, Switzerland|
|Clara Camaschella||Università Vita-Salute San Raffaele, Milan, Italy|
|Jürgen Debus||University Hospital Heidelberg, Germany|
|Angelika Eggert||Charité, Berlin|
|Richard Gilbertson||Cambridge Cancer Centre, Cambridge, UK|
|Doug Higgs||MRC Weatherall Institute of Molecular Medicine, Oxford, UK|
|Paul Northcott||St. Jude Children's Research Hospital, Memphis Tennessee, USA|
|Roland Rad||Klinikum rechts der Isar der TU München, Germany|
|Gudrun Schleiermacher||Institut Curie, Paris, France|
|Louis Stancato||Eli Lilly, Indianapolis, USA|
|Renata Stripecke||Hannover Medical School, Germany|
|Poul Sörensen||BC Children's Hospital, Vancouver, Canada|
|Michael Taylor||The Arthur and Sonia Labatt Brain Tumour Research Centre, University of Toronto, Canada|
|Gilles Vassal||Institut Gustave-Roussy, Villejuif, France|
||Institut Curie, Paris, France|
||Princess Máxima Center, Utrecht, Netherlands|